2-amino-N-cyclohexyl-3-(3,4,5-trimethoxybenzoyl)-4,5-dihydrothieno[2,3-c]pyridine-6(7H)-carbothioamide

ID: ALA526096

PubChem CID: 44580508

Max Phase: Preclinical

Molecular Formula: C24H31N3O4S2

Molecular Weight: 489.66

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(C(=O)c2c(N)sc3c2CCN(C(=S)NC2CCCCC2)C3)cc(OC)c1OC

Standard InChI:  InChI=1S/C24H31N3O4S2/c1-29-17-11-14(12-18(30-2)22(17)31-3)21(28)20-16-9-10-27(13-19(16)33-23(20)25)24(32)26-15-7-5-4-6-8-15/h11-12,15H,4-10,13,25H2,1-3H3,(H,26,32)

Standard InChI Key:  GLVUUJONLZKJIR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   10.7142   -3.4917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8868   -3.4998    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.4820   -4.2193    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9034   -4.9310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7339   -4.9188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1349   -4.1988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1184   -2.7725    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.4669   -2.7897    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6571   -4.2284    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.2367   -3.5185    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6419   -2.7984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9434   -2.7630    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1571   -5.6270    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.7553   -6.3476    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9820   -5.6146    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4981   -7.6565    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.1027   -7.0952    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7775   -7.2547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9389   -6.4434    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3205   -5.9010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5370   -6.1644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3755   -6.9757    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.9976   -7.5236    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9123   -7.2541    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5940   -7.2400    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4322   -8.0490    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    6.9744   -6.6954    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1929   -6.9597    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5758   -6.4129    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7971   -6.6742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6310   -7.4827    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2500   -8.0294    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0352   -7.7678    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 18 19  2  0
  3  9  1  0
  4  5  1  0
  9 10  1  0
  2  3  1  0
  8 11  1  0
 18 23  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
  5  6  2  0
 17 24  1  0
  7 12  1  0
 22 25  1  0
  6  1  1  0
 25 26  2  0
  5 13  1  0
 25 27  1  0
  1  2  2  0
 27 28  1  0
 13 14  1  0
  1  7  1  0
 13 15  2  0
 14 19  1  0
  3  4  2  0
 28 29  1  0
  2  8  1  0
 18 16  1  0
 16 17  1  0
 17 14  2  0
 28 33  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
M  END

Associated Targets(Human)

CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

FM3A (1296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 489.66Molecular Weight (Monoisotopic): 489.1756AlogP: 4.15#Rotatable Bonds: 6
Polar Surface Area: 86.05Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.65CX LogD: 4.65
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.46Np Likeness Score: -0.85

References

1. Romagnoli R, Baraldi PG, Carrion MD, Cruz-Lopez O, Cara CL, Tolomeo M, Grimaudo S, Di Cristina A, Pipitone MR, Balzarini J, Kandil S, Brancale A, Sarkar T, Hamel E..  (2008)  Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerization.,  18  (18): [PMID:18725179] [10.1016/j.bmcl.2008.08.006]

Source